Asha Therapeutics presents at 5th Annual MarketsandMarkets Next-Gen Immuno-Oncology Conference

Jun 21, 2022

1 min read

Updated: May 21, 2025

Sam Shrivastava (Asha CEO) and Dr. Bradlee Heckmann (Asha CSO) present updates on neuro-oncology assets and ASHA-044

Recent Posts

ATLANTA, GA, UNITED STATES, May 20, 2025 /EINPresswire.com/ -- CMT Research Foundation has invested in a research project with Asha...

NEW YORK, April 23, 2025 /PRNewswire/ -- Advancium Health Network, a public charity dedicated to advancing therapies for rare diseases,...